IL0011050551
© PR Newswire
04.02.2026
EVGN
LISTED
TLV
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
News Preview
BMC128 was developed by Biomica, Evogene's subsidiary, and is currently completing Phase 1 clinical study, showing promising early clinical resultsREHOVOT, Israel and SHANGHAI, Feb. 4, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene"), a pioneering computational chemistry company specializing in generative design of small m...
Themefolio
Profiler
Peergroup
© PR Newswire
07.01.2026
EVGN
LISTED
TLV
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
News Preview
Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by leveraging generative chemistry design and patient-derived predictive platformREHOVOT, Israel and BOSTON, January 7, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering computational chemistry compa...
Themefolio
Profiler
Peergroup
© PR Newswire
30.12.2025
EVGN
LISTED
TLV
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
News Preview
REHOVOT, Israel, Dec. 30, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, is pleased to announce the appointment of Dr. Olga Nissan as its Vice President of Business Development...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
20.11.2025
EVGN
LISTED
TLV
Evogene Reports Third Quarter 2025 Financial Results
News Preview
Conference call and webcast: today, November 20, 2025, 9:00 AM ET
Financial Highlights:
During the first nine months ending September 30, 2025, Evogene advanced its strategic transition toward establishing itse...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© PR Newswire
06.11.2025
EVGN
LISTED
TLV
Evogene Schedules Third Quarter 2025 Financial Results Release
News Preview
Zoom conference call scheduled for November 20, 2025, 9:00 AM ET
REHOVOT, Israel, Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for...
Themefolio
Profiler
Peergroup
© PR Newswire
19.08.2025
EVGN
LISTED
TLV
Evogene Reports Second Quarter 2025 Financial Results
News Preview
Conference call and webcast: today, August 19, 2025, 9:00 am ET
Financial Highlights:
The financial results for the first half of 2025 of Lavie Bio, a subsidiary of Evogene and the MicroBoost AI for Ag operations, are presented as a single-line item in Evogene's consolidated statements of profit and loss for the first half of 2025. Their results...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2025
EVGN
LISTED
TLV
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
News Preview
A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia and Gout.
REHOVOT, Israel, Aug. 12, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq, TASE: EVGN), a leading computational biology and chemistry company, today announced a scientific collaboration with the pioneering research grou...
Themefolio
Profiler
Peergroup
© PR Newswire
10.06.2025
EVGN
LISTED
TLV
Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud
News Preview
The new model addresses the challenge of identifying novel small molecules that meet multiple product criteria, an essential requirement for pharma and agriculture applications
REHOVOT, Israel, June 10, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company focused on revolutionizing life-science pr...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
EVGN
LISTED
TLV
Evogene Reports First Quarter 2025 Financial Results
News Preview
Conference call and webcast: today, May 21, 2025, 9:00 am ET
Financial Highlights:
In the first quarter of 2025, total revenues were approximately $2.4 million, compared to approximately $4.2 million in the first quarter of 2024. The first quarter of 2024 revenues included license fee payments totaling $3.5 million - $2.5 million from Lavie Bio's...
Themefolio
Profiler
Peergroup
© PR Newswire
08.05.2025
EVGN
LISTED
TLV
Evogene Schedules First Quarter 2025 Financial Results Release
News Preview
Zoom conference call scheduled for May 21, 2025, 9:00 AM ET
REHOVOT, Israel, May 8, 2025 /PRNewswire/ -- May 8, 2025 - Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the first...
Themefolio
Profiler
Peergroup
© PR Newswire
21.04.2025
EVGN
LISTED
TLV
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio
News Preview
Lavie Bio improves agriculture productivity and sustainability through microbiome-based ag-biological products
REHOVOT, Israel, April 21, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) a leading computational biology company focused on revolutionizing life-science-based product discovery and development, today announced the signing...
Themefolio
Profiler
Peergroup
© PR Newswire
06.03.2025
EVGN
LISTED
TLV
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Conference call and webcast: today, March 6, 2025, 9:00 am ET
Financial Highlights:
In the year 2024, total revenues reached approximately $8.5 million compared to approximately $5.6 million in the year 2023. The increase in revenues is mainly due to increase in AgPlenus' revenues from its collaboration with Bayer and an increase in Casterra's se...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
06.03.2025
EVGN
LISTED
TLV
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025
News Preview
Mr. Nir Nirmodi is Replacing Ms. Sarit Firon, who will Continue Serving as a Member of the Board
REHOVOT, Israel, March 6, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced the appointment of Mr. Nir N...
Themefolio
Profiler
Peergroup
© PR Newswire
20.02.2025
EVGN
LISTED
TLV
Evogene Schedules Fourth Quarter 2024 Financial Results Release
News Preview
Zoom conference call scheduled for March 6, 2025, 9:00 AM ET
REHOVOT, Israel, Feb. 20, 2025 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the fourth quarter o...
Themefolio
Profiler
Peergroup
© PR Newswire
21.11.2024
EVGN
LISTED
TLV
Evogene Reports Third Quarter 2024 Financial Results
News Preview
Conference call and webcast: today, November 21, 2024, 9:00 am ET
Financial Highlights:
In the first nine months of 2024, total revenues reached approximately $6.9 million, compared to approximately $5.1 million in the first nine months of 2023.In Q3 2024, total revenues reached approximately $1.8 million, compared to approximately $3.8 million i...
Themefolio
Profiler
Peergroup
© PR Newswire
19.11.2024
EVGN
LISTED
TLV
Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results
News Preview
LAV321demonstrated strong results in its third consecutive year of field trials in Europe
REHOVOT, Israel, Nov. 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced significant progress in the development of its LAV321 bio-fungicide, targeting downy...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2024
EVGN
LISTED
TLV
Lavie Bio Announces Commercial Expansion of Yalos® as Seed-Treatment for Soybean, Following Successful Field Trials
News Preview
Lavie Bio intends to commence Yalos® sales for soybean in 2025 US spring season
REHOVOT, Israel, Nov. 12, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), today announced the commercial expansion of Yalos® seed-treatment to soybean, following successful field tri...
Themefolio
Profiler
Peergroup
© PR Newswire
07.11.2024
EVGN
LISTED
TLV
Evogene Schedules Third Quarter 2024 Financial Results Release
News Preview
Zoom conference call scheduled for November 21, 2024, 9:00 AM ET
REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the third quarter...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2024
EVGN
LISTED
TLV
Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design
News Preview
The collaboration has the power to foster breakthroughs in small molecule innovation for life science-based products
REHOVOT, Israel, Oct. 31, 2024 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development, today announced a collab...
Themefolio
Profiler
Peergroup
© PR Newswire
29.10.2024
EVGN
LISTED
TLV
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
News Preview
The shipment, comprising over 100 tons, was delivered to company's customer in Africa
REHOVOT, Israel, Oct. 29, 2024 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company for oil production for bio-based products and biofuel, and a subsidiary of Evogene Ltd. ("Evogene") (Nasdaq: EVGN) (TASE: EVGN), today...
Themefolio
Profiler
Peergroup
© PR Newswire
08.10.2024
EVGN
LISTED
TLV
Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology
News Preview
Following a successful first year, Israel Innovation Authority (IIA) approved financing second year of collaboration
HAZEVA and REHOVOT, Israel, Oct. 8, 2024 /PRNewswire/ -- Watershed AC ("Watershed", formerly Colors Farm Ltd.), a cutting-edge company in sustainable aquaculture and biotech and Evogene Ltd. ("Evogene") (NASDAQ: EVGN)(TASE: EVGN),...
Themefolio
Profiler
Peergroup
© PR Newswire
30.09.2024
EVGN
LISTED
TLV
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
News Preview
The technology aims to reduce application costs, extend shelf life, and prolong bacterial viability after field application
REHOVOT, Israel, Sept. 30, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announced receiving a grant from the Israel Innovation Authority...
Themefolio
Profiler
Peergroup
© PR Newswire
23.08.2024
EVGN
LISTED
TLV
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
News Preview
REHOVOT, Israel, Aug. 23, 2024 /PRNewswire/ -- Evogene Ltd. ("Evogene" or the "Company") (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize life-science-based product discovery and development utilizing cutting-edge computational biology technologies across multiple market segments, announced today that it...
Themefolio
Profiler
Peergroup
© PR Newswire
22.08.2024
EVGN
LISTED
TLV
Evogene Reports Second Quarter 2024 Financial Results
News Preview
Conference call and webcast: today, August 22, 2024, 9:00 am ET
Financial and Business Highlights:
H1 2024 revenues $5.1M, up from $1.3M in H1 2023; Q2 2024 revenues $914K, up from $654K in Q2 2023.Anticipated continued revenue growth in the second half of 2024 compared to the same period in the previous year, primarily driven by Casterra's initi...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2024
EVGN
LISTED
TLV
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
News Preview
REHOVOT, Israel, Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize life-science product discovery and development across multiple market segments, today reported the receipt of a formal notification from The Nasdaq Stock Market LLC...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2024
EVGN
LISTED
TLV
Evogene Schedules Second Quarter 2024 Financial Results Release
News Preview
Zoom conference call scheduled for 9:00 AM ET
REHOVOT, Israel, Aug. 12, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and development, announced today that it will release its financial results for the second quarter of 2024, on Thur...
Themefolio
Profiler
Peergroup
© PR Newswire
17.07.2024
EVGN
LISTED
TLV
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants
News Preview
More than one dozen novel microbes identified for row crops suffering from extreme weather conditions
TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN),...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
